Development of Novel Radiopharmaceuticals for SPECT and PET
Pharmaceuticals · 28.05.2026 · 19 (6) · 841
DOI: 10.3390/ph19060841 ↗Kurz gefasst
Editorial in der Zeitschrift Pharmaceuticals, online erschienen am 28.05.2026. Verfasst von Bianca Gutfilen. Beteiligte Einrichtung: Department of Radiology, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-971, Brazil. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nuclear Medicine has experienced remarkable advances over the past few decades, driven primarily by the development of new radiopharmaceuticals for both conventional applications and positron emission tomography (PET) [...]
Autor:innen und Institutionen
- Department of Radiology, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-971, Brazil.
ORCID-Profile: Bianca Gutfilen
Zitieren
APA
Gutfilen, B. (2026). Development of Novel Radiopharmaceuticals for SPECT and PET. Pharmaceuticals, 19(6), 841. https://doi.org/10.3390/ph19060841
Vancouver
Gutfilen B. Development of Novel Radiopharmaceuticals for SPECT and PET. Pharmaceuticals. 2026;19(6):841. doi:10.3390/ph19060841
BibTeX
@article{Gutfilen2026,
author = {Gutfilen, Bianca},
title = {Development of Novel Radiopharmaceuticals for SPECT and PET},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {6},
pages = {841},
doi = {10.3390/ph19060841}
}
EUVIMED